Skip to content
healthcare.dev

regadenoson

NDC 36000-364, regadenoson, injection, solution, from Baxter Healthcare Corporation.

Product NDC
36000-364
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217455
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/36000-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
36000-364-01360000364011 SYRINGE, PLASTIC in 1 CARTON (36000-364-01) / 5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a81d66a7-b714-439e-ad7b-c7caf9d6f3b8
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=36000-364

Use it

Look up 36000-364 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/36000-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 36000-364. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.